Milestone Pharmaceuticals Inc (MIST)
1.72
+0.03
(+1.78%)
USD |
NASDAQ |
May 06, 11:56
Milestone Pharmaceuticals 1 Year Total Returns (Daily): -53.06% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -53.06% |
May 02, 2024 | -53.28% |
May 01, 2024 | -55.80% |
April 30, 2024 | -54.55% |
April 29, 2024 | -56.75% |
April 26, 2024 | -58.49% |
April 25, 2024 | -58.53% |
April 24, 2024 | -57.87% |
April 23, 2024 | -57.71% |
April 22, 2024 | -59.45% |
April 19, 2024 | -57.18% |
April 18, 2024 | -55.95% |
April 17, 2024 | -54.07% |
April 16, 2024 | -50.97% |
April 15, 2024 | -51.11% |
April 12, 2024 | -52.86% |
April 11, 2024 | -55.86% |
April 10, 2024 | -55.47% |
April 09, 2024 | -57.07% |
April 08, 2024 | -53.21% |
April 05, 2024 | -54.55% |
April 04, 2024 | -57.00% |
April 03, 2024 | -55.78% |
April 02, 2024 | -54.31% |
April 01, 2024 | -53.55% |
Date | Value |
---|---|
March 28, 2024 | -55.14% |
March 27, 2024 | -50.00% |
March 26, 2024 | -46.13% |
March 25, 2024 | -48.51% |
March 22, 2024 | -46.46% |
March 21, 2024 | -54.78% |
March 20, 2024 | -54.82% |
March 19, 2024 | -56.06% |
March 18, 2024 | -54.85% |
March 15, 2024 | -58.87% |
March 14, 2024 | -59.54% |
March 13, 2024 | -55.52% |
March 12, 2024 | -53.59% |
March 11, 2024 | -51.88% |
March 08, 2024 | -59.63% |
March 07, 2024 | -60.42% |
March 06, 2024 | -59.50% |
March 05, 2024 | -50.47% |
March 04, 2024 | -51.41% |
March 01, 2024 | -48.73% |
February 29, 2024 | -46.84% |
February 28, 2024 | -32.59% |
February 27, 2024 | -31.03% |
February 26, 2024 | -32.80% |
February 23, 2024 | -48.01% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.08%
Minimum
Jun 30 2020
268.2%
Maximum
Mar 24 2021
-23.62%
Average
-37.93%
Median
Jul 23 2021
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |